Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | TLR4 | O00206 | 6/20 | 0.46 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.43 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.43 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.43 |
| ▸ | BMP2 | P12643 | 1/20 | 0.41 |
| ▸ | VEGFA | P15692 | 1/20 | 0.41 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.41 |
| ▸ | SHH | Q15465 | 1/20 | 0.41 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.41 |
| ▸ | SELP | P16109 | 6/20 | 0.41 |
| ▸ | CD69 | Q07108 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19225344 | 1.00 | MAPK1 (0.47) | MAPK1TLR4LGALS3LGALS8LGALS4 | |
| SCHEMBL19225485 | 1.00 | MAPK1 (0.47) | MAPK1TLR4LGALS3LGALS8LGALS4 | |
| SCHEMBL19220659 | 1.00 | MAPK1 (0.47) | MAPK1TLR4LGALS3LGALS8LGALS4 | |
| SCHEMBL19220670 | 1.00 | MAPK1 (0.47) | MAPK1TLR4LGALS3LGALS8LGALS4 | |
| SCHEMBL16433869 | 1.00 | MAPK1 (0.47) | MAPK1TLR4LGALS3LGALS8LGALS4 | |
| SCHEMBL23773084 | 1.00 | MAPK1 (0.47) | MAPK1TLR4LGALS3LGALS8LGALS4 | |
| SCHEMBL20685523 | 1.00 | MAPK1 (0.47) | MAPK1TLR4LGALS3LGALS8LGALS4 | |
| SCHEMBL21888384 | 1.00 | MAPK1 (0.47) | MAPK1TLR4LGALS3LGALS8LGALS4 | |
| SCHEMBL21565221 | 1.00 | MAPK1 (0.47) | MAPK1TLR4LGALS3LGALS8LGALS4 | |
| SCHEMBL20390691 | 1.00 | MAPK1 (0.47) | MAPK1TLR4LGALS3LGALS8LGALS4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170223956-A1 | LIPO-CHITOOLIGOSACCHARIDE COMPOSITIONS FOR ENHANCING PLANT GROWTH | NOVOZYMES BIOAG A/S (DK) | 2017-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170223956-A1 | LIPO-CHITOOLIGOSACCHARIDE COMPOSITIONS FOR ENHANCING PLANT GROWTH | CHIT1, LPO, DDOST | MAPK1 4270/4885TLR4 911/4885LGALS3 180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.